Ayesha Sitlani

Ayesha Sitlani is an accomplished professional in the biochemistry and biopharmaceutical fields, currently serving as Acting Head of Translational Medicine and Associate Vice President of Antibody Strategy at IAVI since January 2018. Prior to this role, Ayesha held multiple leadership positions at Merck and Co., Inc. from 1998 to 2018, including Executive Director in both Bioanalytical Development for Biologics and Vaccines Clinical Assays and Chief of Staff for the Biologics organization, where strategic initiatives were initiated and managed across various sites. Ayesha's educational background includes a PhD in Biochemistry from California Institute of Technology, a Postdoctoral Fellowship in Biophysical Chemistry from Yale University, and degrees in Chemistry and Psychology from Smith College.